12 results
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
demographics, as well as the large number of clinical trial sites and additional countries and languages involved in such trials. Any
424B3
LSB
LakeShore Biopharma Co., Ltd
15 Aug 23
Prospectus supplement
8:00am
complexity due to the involvement of diversified demographics, as well as the large number of clinical trial sites and additional countries and languages
POS AM
LSB
LakeShore Biopharma Co., Ltd
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
of participants and resulting complexity due to the involvement of diversified demographics, as well as the large number of clinical trial sites and additional
20-F
2023 FY
LSB
LakeShore Biopharma Co., Ltd
26 Jul 23
Annual report (foreign)
4:02pm
complexity due to the involvement of diversified demographics, as well as the large number of clinical trial sites and additional countries and languages
424B3
wbxw6sgr
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
955krgoor8
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
qgeotx2o
12 Apr 23
Registration statement (foreign)
8:49am
F-4
iqsvsmz4
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
rgon6mw
7 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
o0yiiyjlev
14 Nov 22
Draft registration statement (amended)
12:00am
DRS
do9vjlrblti5twa
3 Oct 22
Draft registration statement
12:00am
- Prev
- 1
- Next